1
项与 WT1 mRNA-electroporated Langerhans cells(Memorial Sloan Kettering Cancer Center) 相关的临床试验A Phase I Trial of Vaccination With CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
The purpose of this study is to see if the investigator can help the immune system to work against myeloma.
This study will see if a vaccine made with altered dendritic cells will make T cells work against tumor cells. The stem cells collected for the transplant will also be used to grow dendritic cells in the lab. The dendritic cells will carry the antigens. These cells then will be injected under the skin. The investigators will do lab studies before and after the vaccination to find out if the vaccine is working.
100 项与 WT1 mRNA-electroporated Langerhans cells(Memorial Sloan Kettering Cancer Center) 相关的临床结果
100 项与 WT1 mRNA-electroporated Langerhans cells(Memorial Sloan Kettering Cancer Center) 相关的转化医学
100 项与 WT1 mRNA-electroporated Langerhans cells(Memorial Sloan Kettering Cancer Center) 相关的专利(医药)
100 项与 WT1 mRNA-electroporated Langerhans cells(Memorial Sloan Kettering Cancer Center) 相关的药物交易